Eloxx Pharmaceuticals,
ELOXPharmaceuticals · NASDAQ · IPO June 9, 2026
01
Company Overview
Eloxx Pharmaceuticals, is filing to list on NASDAQ Capital. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Eloxx Pharmaceuticals, is going public on NASDAQ Capital on 2026-06-09. Offering 2,975,000 shares.
Recent headlines
- ELOX - Eloxx Pharmaceuticals, Inc. | News | OTC Marketsotcmarkets.com
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million. Stock 11.93 -0.115 -0.95% Delayed (15 Min) Trade Data: 12:00am 06/29/2026 … $9. ...
- Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million ...biospace.com
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq June 9, 2026 … price of $11.00 per share
- ELOX Eloxx Pharmaceuticals, Inc. - Yahoo Financefinance.yahoo.com
ELOX Eloxx Pharmaceuticals, Inc. 12.14 -3.38% SUMMARY NEWS. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq. ELOX 25.65% S&P 500
- Eloxx plans stock and warrant sale for Nasdaq relist | ELOX IPO ...stocktitan.net
Eloxx Pharmaceuticals files an S-1/A to sell 1.5M shares plus up to 4M pre-funded warrants, aiming for a Nasdaq Capital Market listing while ...
- ELOX Stock Price and Chart — NASDAQ:ELOX - TradingViewtradingview.com
The current price of ELOX is 13.00 USD — it has increased by 16.35% in the past 24 hours. Watch Eloxx Pharmaceuticals, Inc. stock price performance more closely ...
02
AI Analysis
Possible growth narrative
Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- June 9, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Pharmaceuticals
- Valuation
- $0.00B mkt cap
- Headquarters
- US
- Attention score
- 46 / 100
- Ticker
- ELOX